Showing results (1-10 of 312) with videos related to
Sort By:
Pageof 32
Cancer Cell|September 6, 2008
Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosisMarissa V Powers, Paul A Clarke, Paul WorkmanCell Cycle (Georgetown, Tex.)|February 7, 2009
Death by chaperone: HSP90, HSP70 or both?Marissa V Powers, Paul A Clarke, Paul WorkmanFEBS Letters|June 15, 2007
Inhibitors of the heat shock response: biology and pharmacologyMarissa V Powers, Paul WorkmanEndocrine-Related Cancer|January 30, 2007
Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitorsMarissa V Powers, Paul WorkmanOncotarget|November 5, 2013
Mode of cell death induced by the HSP90 inhibitor 17-AAG (tanespimycin) is dependent on the expression of pro-apoptotic BAXMarissa V Powers, Melanie Valenti, Susana Miranda, et al.Cancer Cell|April 13, 2011
Resisting targeted therapy: fifty ways to leave your EGFRPaul Workman, Paul A ClarkeCurrent Cancer Drug Targets|October 8, 2003
Genes and proteins governing the cellular sensitivity to HSP90 inhibitors: a mechanistic perspectiveAlison Maloney, Paul A Clarke, Paul WorkmanMolecular Oncology|March 24, 2012
Discovery of small molecule cancer drugs: successes, challenges and opportunitiesSwen Hoelder, Paul A Clarke, Paul WorkmanOncotarget|January 29, 2016
Blocking the survival of the nastiest by HSP90 inhibitionPaul Workman, Paul A Clarke, Bissan Al-LazikaniPageof 32